ATM and neoplasm: Four of 6 ATM GVs detected in glioma patients here were LoF variants (two were ClinVar LP/P variants) that resulted in decreased ATM expression in the glioma tissue compared to gliomas from non-ATM GV carriers, thus impacting the molecular phenotype of the tumor.